The angiotensin II type 1 receptor antagonist olmesartan preserves cerebral blood flow and cerebrovascular reserve capacity, and accelerates rehabilitative outcomes in hypertensive patients with a history of stroke

International Journal of Neuroscience

Volumn 120, Issue 5, 2010, Pages 372-380

  Matsumoto, Shuji ^a   Shimodozono, Megumi ^a   Miyata, Ryuji ^a   Kawahira, Kazumi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cerebral blood flow; Cerebrovascular reactivity; Hypertension; Olmesartan; Stroke

Indexed keywords

ACETAZOLAMIDE; OLMESARTAN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CLINICAL ARTICLE; COGNITION; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; HEMIPLEGIA; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; RANGE OF MOTION; SPEECH THERAPY; STROKE; TREATMENT OUTCOME;

ACETAZOLAMIDE; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; BRAIN; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; STROKE; TETRAZOLES; TREATMENT OUTCOME;

EID: 77951467543     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207450903389362     Document Type: Article

References (29)

1. Barry, D. I., Jarden, J. O., Paulson, O. B., Graham, D. I., & Strandgaard, S. (1984). Cerebrovascular aspects of convertingenzyme inhibition. I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats. Journal of Hypertension, 2, 589-597.
2. Brunnstrom, S. (1970). Movement Therapy in Hemiplegia: A Neurophysiological Approach. New York: Harper & Row.
3. Folstein, M. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189.
4. Gur, D., Yonas, H., & Good, W. F. (1989). Local cerebral blood flow by xenon-enhanced CT:Current status, potential improvements, and future directions. Cerebrovascular and Brain Metabolism Reviews, 1, 68-86.
5. Howanitz, E. M., Wisotzek, I. E., Losonczy, M. F., & Schaffer, C. (2001). The relationship between mental status examination scores and cerebral blood flow in geriatric schizophrenia. Schizophrenia Research, 49, 228-229.
6. Ishikawa, J., Kario, K., Hoshige, S., Eguchi, K., Kaneda, R., Umeda, Y., et al.. (2005). Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) study. American Journal of Hypertension, 18, 958-965.
7. Jarden, J. O., Barry, D. I., Juhler, M., Graham, D. I., Strandgaard, S., & Paulson, O. B. (1984). Cerebrovascular aspects of convertingenzyme inhibition II: Blood-brain barrier permeability and effect of intracerebroventricular administration of captopril. Journal of Hypertension, 2, 599-604.
8. Jorgensen, H. S., Nakayama, H., Raaschou, H. O., Vive-Larsen, J., Stolier, M., & Olsen, T. S. (1995). Outcome and time course of recovery in stroke. Part II: Time course of recovery. The Copenhagen stroke study. Archives of Physical Medicine and Rehabilitation, 76, 406-412.
9. Kario, K., Pickering, T. G., Umeda, Y., Hoshide, S., Hoshide, Y., Morinari,M., et al. (2003).Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation, 107, 1401-1406.
10. Kitagawa, Y., Meyer, J. S., Tachibana, H., Mortel, K. F., & Rogers, R. L. (1984). CT-CBF correlation of cognitive deficits in multiinfarct dementia. Stroke, 15, 1000-1009.
11. Kretschmann, H. J., &Weinrich,W. (1986). Neuroanatomy and Cranial Computed Tomography. New York: Thieme.
12. Kuriyama, Y., Sawada, T., & Omae, T. (1989). Anitihypertensive drugs and cerebral circulation. In T. Omae and A. Zanchetti (eds.),How should Elderly Hypertensive Patients be Treated? Tokyo, Japan: Springer, 69-81.
13. Mahoney, F., & Barthel, D. (1965). Functional evaluation: The Barthel index. Maryland State Medical Journal, 14, 61.
14. Meyer, J. S., Shinohara, T., Imai, A., Kobari, M., Sakai, F., Hata, T., et al. (1988). Imaging local cerebral blood flow by xenonenhanced computed tomography: Technical optimization procedures. Neuroradiology, 30, 283-292.
15. Miura, S., Fujino, M., Hanzawa, H., Kiya, Y., Imaizumi, S., Matsuo, Y., et al. (2006). Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. The Journal of Biological Chemistry, 281, 19288-19295.
16. Moriwaki, H., Uno, H., Nagakane, Y., Hayashida, K., Miyashita, K., & Naritomi, H. (2004). Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stoke. Journal of Human Hypertension, 18, 693-699.
17. Nishimura, Y., Ito, T., & Saavedra, J. M. (2000). Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke, 31, 2478-2486.
18. Nogami, K., Fujii, M., Kato, S., Nishizaki, T., Suzuki,M., Yamashita, S., et al. (2004). Analysis of magnetic resonance imaging (MRI) morphometry and cerebral blood flow in patients with hypoxicischemic encephalopathy. Journal of Clinical Neuroscience, 11, 376-380.
19. Oku, N., Kitagawa, K., Imaizumi, M., Takasawa, M., Piao, R., Kimura, Y., et al. (2005). Hemodynamic influences of losartan on the brain in hypertensive patients. Hypertension Research, 28, 43-48.
20. Okudaira, Y., Nakanishi, H., Arai, H., & Sato, K. (2003). Differences in acetazolamide vasoreactivity in patients with acute and chronic occlusion of the internal carotid artery. Journal of Clinical Neuroscience, 10, 316-319.
21. Oparil, S.,Williams, D., Chrysant, S. G., Marbury, T. C., & Neutel, J. (2001). Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension. Journal of Clinical Hypertension, 3, 283-291.
22. Paulson, O. B., Jarden, J. O., Vorstrup, S., Holm, S., & Godtfredsen, J. (1986). Effect of captopril on the cerebral circulation in chronic heart failure. European Journal of Clinical Investigation, 16, 124-132.
23. Rogers, R. L., Meyer, J. S.,Mortel, K. F.,Mahurin, R. K., & Judd, B. W. (1986). Decreased cerebral blood flow precedes multi-infarct dementia, but flows senile dementia of Alzheimer type. Neurology, 36, 1-6.
24. Smith, D. H., Dubiel, R., & Jones, M. (2005). Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: A comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan. American Journal of Cardiovascular Drugs, 5, 41-50.
25. Strandgaard, S., Olesen, J., Skinhoj, E., & Lassen, N. A. (1973). Autoregulation of brain circulation in severe arterial hypertension. British Medical Journal, 1, 507-510.
26. Stromberg, C., Naveri, L., & Saavedra, J. M. (1993). Nonpeptide angiotensin AT1 and AT2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats. Journal of Cerebral Blood Flow and Metabolism, 13, 298-303.
27. Ullman, J. S., & Bederson, J. B. (1996). Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. Is it efficacious? Yes. Critical Care Clinics, 12, 697-1670
28. Vraamark, T., Waldemar, G., Strandgaard, S., & Paulson, O. B. (1995). Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. Journal of Hypertension, 13, 755-761.
29. White, W. B. (2001). Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Pressure Monitoring, 6, 63-72.